New thyroid drug shows promise in phase 2 trial
Disease control
Completed
This study tested a new hormone replacement therapy called North Star against the standard drug levothyroxine in 303 adults with hypothyroidism. The goal was to find the right dose of North Star to keep thyroid hormone levels normal. Participants were already stable on levothyrox…
Phase: PHASE2 • Sponsor: Neuvosyn Laboratories, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC